[Form 4] Curtiss-Wright Corp. Insider Trading Activity

Rhea-AI Filing Summary

The Form 4 filing discloses that Curtiss-Wright Corp. (CW) Vice President & CFO K. Christopher Farkas acquired 30 shares of common stock on July 2, 2025 through the company’s Employee Stock Purchase Plan (ESPP). The purchase was coded “A” (acquisition) and is exempt under Rule 16b-3. The effective purchase price was $414.23 per share, reflecting the ESPP’s 15% discount to the average market price on June 30, 2025. Following the transaction, Farkas directly owns 9,283 shares of CW common stock. No derivative securities were reported, and there were no dispositions. The filing represents a routine, small-scale increase in insider ownership rather than a strategic shift.

Insights

Corporate Governance Analyst

TL;DR: Minor ESPP buy; neutral governance signal.

The CFO’s purchase of 30 shares, worth roughly US$12,400, is immaterial relative to Curtiss-Wright’s market capitalization and to his existing 9,283-share stake. Because the acquisition was executed via the ESPP, it reflects automatic payroll deductions rather than discretionary buying. Such routine purchases generally carry limited informational value for investors and do not suggest a change in management’s outlook or insider sentiment. I classify the impact on shareholder perception and valuation as neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Farkas K Christopher

(Last) (First) (Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON NC 28036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President and CFO

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2025		A(1)		30	A	$414.23(2)	9,283	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

2. In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2025, the last day of the offering period.

Remarks:

	George P. McDonald by Power of Attorney from K. Christopher Farkas	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CW's CFO report on Form 4?

K. Christopher Farkas acquired 30 CW common shares through the Employee Stock Purchase Plan.

When did the Curtiss-Wright (CW) insider purchase occur?

The transaction date listed is July 2, 2025.

What was the purchase price in the Curtiss-Wright ESPP transaction?

The effective price was $414.23 per share, reflecting a 15% ESPP discount.

How many CW shares does the CFO own after the transaction?

After the purchase, Farkas directly owns 9,283 CW shares.

Was the acquisition discretionary or part of a plan?

It was automatic under the Employee Stock Purchase Plan and exempt under Rule 16b-3.